GenMark Diagnostics

Latest Headlines

Latest Headlines

GenMark raising $60M as it moves on from stock plunge

GenMark Diagnostics is selling off $60 million in common stock, looking to scrape together some cash and move on from an early summer fright that sent investors reeling.

For GenMark, more flu was good news in 2012

Thanks in part to a really nasty flu season, GenMark Diagnostics ended 2012 with a big boost in revenue.

GenMark's revenue soars as loss narrows

GenMark Diagnostics posted a four-fold revenue jump in the third quarter, as the company increased its analyzer placements and boosted its reagent sales by almost 5 times.

2012: A lackluster year for medical device and diagnostics IPOs

Put lightly, it was less than a banner year for medical device and diagnostics companies looking to go public. Check out the report >>

GenMark Diagnostics seeks $42M in public offering

Plans call for using the proceeds to expand test offering menu options and accelerate other product development. But the big focus here with the cash infusion will be to grow U.S. and global commercial operations.

GenMark IPO price range lowered

Pasadena, California-based GenMark Diagnostics recently announced that its initial public offering of 4.6 million shares of its common stock has been priced at $6 per share. However, as Reuters